| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6177027 | European Urology | 2013 | 8 Pages |
Abstract
Intermediate-risk PCa is a heterogeneous collection of diseases that can be separated into favorable and unfavorable subsets. These groups likely will benefit from divergent therapeutic paradigms.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Zachary S. Zumsteg, Daniel E. Spratt, Isaac Pei, Zhigang Zhang, Yoshiya Yamada, Marisa Kollmeier, Michael J. Zelefsky,